1. Home
  2. PLRX vs ODC Comparison

PLRX vs ODC Comparison

Compare PLRX & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • ODC
  • Stock Information
  • Founded
  • PLRX 2015
  • ODC 1941
  • Country
  • PLRX United States
  • ODC United States
  • Employees
  • PLRX N/A
  • ODC N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • PLRX Health Care
  • ODC Consumer Discretionary
  • Exchange
  • PLRX Nasdaq
  • ODC Nasdaq
  • Market Cap
  • PLRX 641.5M
  • ODC 436.2M
  • IPO Year
  • PLRX 2020
  • ODC N/A
  • Fundamental
  • Price
  • PLRX $11.77
  • ODC $41.05
  • Analyst Decision
  • PLRX Strong Buy
  • ODC
  • Analyst Count
  • PLRX 7
  • ODC 0
  • Target Price
  • PLRX $40.50
  • ODC N/A
  • AVG Volume (30 Days)
  • PLRX 544.4K
  • ODC 45.6K
  • Earning Date
  • PLRX 02-26-2025
  • ODC 03-06-2025
  • Dividend Yield
  • PLRX N/A
  • ODC 1.51%
  • EPS Growth
  • PLRX N/A
  • ODC 36.22
  • EPS
  • PLRX N/A
  • ODC 3.09
  • Revenue
  • PLRX N/A
  • ODC $454,094,000.00
  • Revenue This Year
  • PLRX N/A
  • ODC N/A
  • Revenue Next Year
  • PLRX N/A
  • ODC N/A
  • P/E Ratio
  • PLRX N/A
  • ODC $13.32
  • Revenue Growth
  • PLRX N/A
  • ODC 6.61
  • 52 Week Low
  • PLRX $10.22
  • ODC $29.48
  • 52 Week High
  • PLRX $18.92
  • ODC $46.50
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 34.86
  • ODC 49.09
  • Support Level
  • PLRX $12.40
  • ODC $40.66
  • Resistance Level
  • PLRX $13.71
  • ODC $42.45
  • Average True Range (ATR)
  • PLRX 0.76
  • ODC 1.28
  • MACD
  • PLRX -0.17
  • ODC -0.61
  • Stochastic Oscillator
  • PLRX 18.66
  • ODC 7.84

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: